Danish biotech Genmab has appointed Martine van Vugt to the role of chief strategy officer, overseeing corporate strategy, licensing and business development, a 28 March 2023
Antisense oligonucleotide (ASO) firm Secarna Pharmaceuticals has partnered with fellow German company SciNeuro Pharmaceuticals to take aim at central nervous sy 28 March 2023
A new immunology company, NImmune Biopharma, has been launched to develop omilancor, NIM-1324, and the entire LANCL portfolio, which it has bought from Landos B 24 March 2023
Canada’s AbCellera and British firm RQ Bio will work together to identify clinical candidates for up to three infectious disease targets, under the terms of a n 22 March 2023
Psychiatric and neurologic condition specialist Karuna Therapeutics has announced a public stock offering, with the goal of raising $400 million. 21 March 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.